Stockreport

BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference

BridgeBio Oncology Therapeutics, Inc.  (BBOT) 
PDF SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical compan [Read more]